These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16088009)

  • 1. Factors that influence staffing of outpatient substance abuse treatment programs.
    Lemak CH; Alexander JA
    Psychiatr Serv; 2005 Aug; 56(8):934-9. PubMed ID: 16088009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why do drug treatment organizations use contingent staffing arrangements? An analysis of market and social influences.
    Lemak CH; Alexander JA; Roy J
    J Health Soc Behav; 2003 Jun; 44(2):180-97. PubMed ID: 12866389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do licensing and accreditation matter in outpatient substance abuse treatment programs?
    Wells R; Lemak CH; Alexander JA; Nahra TA; Ye Y; Campbell CI
    J Subst Abuse Treat; 2007 Jul; 33(1):43-50. PubMed ID: 17588488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ownership differences in the provision of outpatient substance abuse services.
    Burke AC; Rafferty JA
    Adm Soc Work; 1994; 18(3):59-91. PubMed ID: 10138940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Program structure, staff perceptions, and client engagement in treatment.
    Broome KM; Flynn PM; Knight DK; Simpson DD
    J Subst Abuse Treat; 2007 Sep; 33(2):149-58. PubMed ID: 17434709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administrative burden and its implications for outpatient substance abuse treatment organizations.
    Lemak CH; Alexander JA; Campbell C
    Psychiatr Serv; 2003 May; 54(5):705-11. PubMed ID: 12719502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public substance abuse and managed behavioral healthcare. American Managed Behavioral Healthcare Association and National Association of State Alcohol and Drug Abuse Directors, Inc.
    Behav Healthc Tomorrow; 1999 Feb; 8(1):25-30. PubMed ID: 10346117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organizational- and individual-level correlates of posttreatment substance use: a multilevel analysis.
    Ghose T
    J Subst Abuse Treat; 2008 Mar; 34(2):249-62. PubMed ID: 17600654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organizational survival in the outpatient substance abuse treatment sector, 1988-2000.
    Wells R; Lemak CH; D'Aunno TA
    Med Care Res Rev; 2005 Dec; 62(6):697-719. PubMed ID: 16330821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Program structure and counselor-client contact in outpatient substance abuse treatment.
    Knight DK; Broome KM; Simpson DD; Flynn PM
    Health Serv Res; 2008 Apr; 43(2):616-34. PubMed ID: 18370970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective contracting in managed care: the case of substance abuse treatment.
    Lemak CH; Alexander JA; D'Aunno TA
    Med Care Res Rev; 2001 Dec; 58(4):455-81. PubMed ID: 11759199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supervisor ideology and organizational response: HIV/AIDS prevention in outpatient substance abuse treatment units.
    Clapp JD; Burke AC
    Adm Soc Work; 1997; 21(1):49-64. PubMed ID: 10166759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health services for women in outpatient substance abuse treatment.
    Campbell CI; Alexander JA
    Health Serv Res; 2005 Jun; 40(3):781-810. PubMed ID: 15960691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two separate tracks? A national multivariate analysis of differences between public and private substance abuse treatment programs.
    Rodgers JH; Barnett PG
    Am J Drug Alcohol Abuse; 2000 Aug; 26(3):429-42. PubMed ID: 10976667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with interorganizational relationships among outpatient drug treatment organizations 1990-2000.
    Wells R; Lemak CH; D'Aunno TA
    Health Serv Res; 2005 Oct; 40(5 Pt 1):1356-78. PubMed ID: 16174138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organizational correlates of access to primary care and mental health services in drug abuse treatment units.
    Friedmann PD; Alexander JA; D'Aunno TA
    J Subst Abuse Treat; 1999 Jan; 16(1):71-80. PubMed ID: 9888124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of alternative staff time data collection methods on drug treatment service cost estimates.
    Zarkin GA; Dunlap LJ; Wedehase B; Cowell AJ
    Eval Program Plann; 2008 Nov; 31(4):427-35. PubMed ID: 18640722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurse staffing.
    Prairie Rose; 2005 Nov-2006 Jan; 74(4):18-9. PubMed ID: 16594185
    [No Abstract]   [Full Text] [Related]  

  • 20. Standards approved for health care staffing services program.
    Jt Comm Perspect; 2004 Sep; 24(9):10-1. PubMed ID: 15484655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.